Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363220130510090743
Korean Journal of Dermatology
2013 Volume.51 No. 9 p.743 ~ p.745
A Case of Psoriasiform Dermatitis Following Adalimumab Injection for Treatment of Ankylosing Spondylitis
Hahn Hyung-Jin

Jung Jae-Wook
Park Hyun-Jung
Lee Yang-Won
Choe Yong-Beom
Ahn Kyu-Joong
Abstract
Adalimumab (HumiraTM) is the first fully humanized monoclonal TNF-¥áantibody that antagonizes the effects of TNF-¥á. Its use has been found in the treatment of various rheumatologic disorders, namely rheumatoid arthritis,Crohn``s disease, and ankylosing spondylitis, as well as for various skin conditions such as psoriasis. As the use of this particular biologic agent is becoming more widespread, cutaneous adverse effects of the drug is now being reported at a steady rate. The authors herein report a case of 32 year-old female who presented with multiple psoriasiform eruptions on her trunk, back and lower extremities. She had a four-year history of ankylosing spondylitis,for which she was started on subcutaneous adalimumab injection monthly, three and a half years prior to her initial visit.
KEYWORD
Adalimumab, Psoriasiform eruption
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø